TBX3

T-box transcription factor 3, the group of T-box transcription factors

Basic information

Region (hg38): 12:114670255-114684175

Previous symbols: [ "UMS" ]

Links

ENSG00000135111NCBI:6926OMIM:601621HGNC:11602Uniprot:O15119AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • ulnar-mammary syndrome (Definitive), mode of inheritance: AD
  • heart conduction disease (Limited), mode of inheritance: AD
  • ulnar-mammary syndrome (Strong), mode of inheritance: AD
  • ulnar-mammary syndrome (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ulnar-Mammary syndromeADCardiovascularCardiac anomalies, including arrhythmias, have been reported, and surveillance may allow early detection and managementCardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal9207801; 12116211; 12668170; 19938096; 21199695; 28145909

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TBX3 gene.

  • Ulnar-mammary_syndrome (345 variants)
  • TBX3-related_disorder (214 variants)
  • Inborn_genetic_diseases (88 variants)
  • not_provided (63 variants)
  • not_specified (7 variants)
  • Obesity (1 variants)
  • Eccrine_porocarcinoma (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TBX3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005996.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
151
clinvar
11
clinvar
165
missense
4
clinvar
267
clinvar
16
clinvar
3
clinvar
290
nonsense
6
clinvar
1
clinvar
7
start loss
1
1
frameshift
9
clinvar
7
clinvar
2
clinvar
18
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
1
clinvar
7
Total 18 14 275 167 14

Highest pathogenic variant AF is 0.00000137439

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TBX3protein_codingprotein_codingENST00000257566 813911
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9890.0109125744041257480.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.733434460.7690.00002564767
Missense in Polyphen95168.680.563211900
Synonymous-0.8582162011.080.00001341520
Loss of Function4.00222.40.08920.00000109268

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.000008790.00000879
Middle Eastern0.00005440.0000544
South Asian0.00003800.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional repressor involved in developmental processes. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence. {ECO:0000269|PubMed:10468588, ECO:0000269|PubMed:22002537}.;
Pathway
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Mesodermal Commitment Pathway;Preimplantation Embryo (Consensus)

Recessive Scores

pRec
0.191

Intolerance Scores

loftool
0.00413
rvis_EVS
-0.73
rvis_percentile_EVS
14.08

Haploinsufficiency Scores

pHI
0.932
hipred
Y
hipred_score
0.809
ghis
0.653

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.975

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tbx3
Phenotype
skeleton phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
tbx3a
Affected structure
fin bud
Phenotype tag
abnormal
Phenotype quality
aplastic

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;skeletal system development;blood vessel development;in utero embryonic development;heart looping;outflow tract morphogenesis;atrioventricular bundle cell differentiation;regulation of transcription by RNA polymerase II;cell aging;positive regulation of cell population proliferation;anterior/posterior axis specification, embryo;animal organ morphogenesis;specification of animal organ position;stem cell population maintenance;limbic system development;male genitalia development;female genitalia development;negative regulation of epithelial cell differentiation;mammary gland development;luteinizing hormone secretion;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;forelimb morphogenesis;embryonic digit morphogenesis;negative regulation of apoptotic process;negative regulation of myoblast differentiation;positive regulation of cell cycle;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;follicle-stimulating hormone secretion;mesoderm morphogenesis;roof of mouth development;ventricular septum morphogenesis;branching involved in mammary gland duct morphogenesis;mammary placode formation;cardiac muscle cell fate commitment;sinoatrial node cell development;cellular senescence;positive regulation of stem cell proliferation
Cellular component
nucleus
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;RNA polymerase II activating transcription factor binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding